《Nature,3月18日,Coronavirus vaccines: five key questions as trials begin》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-19
  • The push to make a coronavirus vaccine is moving at breakneck speed. This week, the first of a few dozen healthy volunteers in Seattle, Washington, received a vaccine in a phase 1 safety trial sponsored by the US government. Similar safety trials of other coronavirus vaccines will also begin soon.

  • 原文来源:https://www.nature.com/articles/d41586-020-00798-8
相关报告
  • 《Nature,3月17日,Coronavirus latest: First vaccine clinical trials begin in United States》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-18
    • 17 March 00:30 GMT — First vaccine clinical trials begin in the United States The first phase I clinical trial for a potential COVID-19 vaccine has begun in Seattle, Washington. Four adults, the first of 45 eventual participants, received their first doses of an experimental vaccine developed through a partnership between the US National Institute of Allergy and Infectious Diseases (NIAID) and Moderna, a biotechnology company based in Cambridge, Massachusetts. But although it is an important milestone, the phase I trial is just the beginning of a long process to test the drug’s safety and efficacy.
  • 《Nature,3月25日,Cancer drug trials on hold amid coronavirus disruption》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-26
    • When 2020 began, Neena Nizar and her family were poised to harvest the fruit of a decade of hard work and sacrifice: a clinical trial of an experimental treatment for her two sons’ rare genetic disorder that was slated to start before the year’s end. “I can’t even put into words what we’ve been able to do to get to this point,” she says. “My kids have given bone biopsies; I gave up my job and moved to a new country. We’ve just been going, going, going.”